| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  | 
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  | 
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | 
|  | ||
| (Address of principal executive offices) | (Zip Code) | 
| Title of each class registered | Trading Symbol(s) | Name of each exchange on which registered | ||
| one-halfof one redeemable warrant | ||||
| the units | ||||
| the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 | 
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
| Page No. | ||||||
| PART I. FINANCIAL INFORMATION | ||||||
| Item 1. | 1 | |||||
| 1 | ||||||
| 2 | ||||||
| 3 | ||||||
| 4 | ||||||
| 5 | ||||||
| Item 2. | 20 | |||||
| Item 3. | 22 | |||||
| Item 4. | 22 | |||||
| PART II. OTHER INFORMATION | ||||||
| Item 1. | 24 | |||||
| Item 1A. | 24 | |||||
| Item 2. | 24 | |||||
| Item 3. | 24 | |||||
| Item 4. | 24 | |||||
| Item 5. | 24 | |||||
| Item 6. | 25 | |||||
| 26 | ||||||
| • | our ability to select an appropriate target business or businesses;  | 
| • | our ability to complete our initial business combination;  | 
| • | our expectations around the performance of the prospective target business or businesses;  | 
| • | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;  | 
| • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;  | 
| • | our potential ability to obtain additional financing to complete our initial business combination;  | 
| • | our pool of prospective target businesses;  | 
| • | our ability to consummate an initial business combination due to the uncertainty resulting from the  COVID-19pandemic and other events (such as an outbreak or escalation of armed hostilities or acts of war, terrorist attacks, natural disasters or other significant outbreaks of infectious diseases); | 
| • | the ability of our officers and directors to generate a number of potential business combination opportunities;  | 
| • | our public securities’ potential liquidity and trading;  | 
| • | the lack of a market for our securities;  | 
| • | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;  | 
| • | the trust account not being subject to claims of third parties; or  | 
| • | our financial performance following our initial public offering.  | 
| March 31, 2022 | December 31, 2021 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Prepaid expenses | ||||||||
|  |  |  |  | |||||
| Total current assets | ||||||||
| Investments held in Trust Account | ||||||||
|  |  |  |  | |||||
| TOTAL ASSETS | $ | $ | ||||||
|  |  |  |  | |||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued offering costs | ||||||||
| Due to Sponsor | ||||||||
| Accrued expenses | ||||||||
| Accrued expenses - related party | ||||||||
|  |  |  |  | |||||
| Total current liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
|  |  |  |  | |||||
| Total liabilities | ||||||||
| Commitments and Contingencies (Note 6) | ||||||||
| Class A ordinary shares subject to possible redemption,  and  shares at redemption value of $ at March 31, 2022 and December 31, 2021, respectivel y |  | |||||||
| Shareholders’ Deficit | ||||||||
| Preference shares, $ | ||||||||
| Class A ordinary shares, $ e xcluding  | ||||||||
| Class B ordinary shares, $  at March 31, 2022 and December 31, 2021, respectively (1) | ||||||||
| Additional  paid-incapital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
|  |  |  |  | |||||
| Total Shareholders’ Deficit | ( | )  | ( | )  | ||||
|  |  |  |  | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | $ | $ | ||||||
|  |  |  |  | |||||
| (1) | Includes up to  | 
| Three Months Ended March 31, 2022 | For the Period From February 3, 2021 (Inception) Through March 31, 2021 | |||||||
| Formation and operating costs | $ | $ | ||||||
|  |  |  |  | |||||
| Loss from operations | ( | )  | ( | )  | ||||
| Loss on sale of Private Placement Warrants | ( | ) | — | |||||
| Gain on investments held in Trust Account | — | |||||||
|  |  |  |  | |||||
| Net loss | $ | ( | )  | $ | ( | )  | ||
|  |  |  |  | |||||
| Basic and diluted weighted average shares outstanding, Class A ordinary shares | — | |||||||
|  |  |  |  | |||||
| Basic and diluted net loss per share, Class A ordinary shares | $ | ( | ) | $ | — | |||
|  |  |  |  | |||||
| Basic and diluted weighted average shares outstanding, Class B ordinary shares | ||||||||
|  |  |  |  | |||||
| Basic and diluted net loss per share, Class B ordinary shares | $ | ( | ) | $ | ( | ) | ||
|  |  |  |  | |||||
| Class A Ordinary Shares | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholders’ Deficit | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||
| Balance at December 31, 2021 | $ | $ | $ | $ | ( | )  | $ | ( | )  | |||||||||||||||||||
| Proceeds from Initial Public Offering allocated to Public Warrants, net of offering costs | — | — | — | — | — | |||||||||||||||||||||||
| Issuance of Private Placement Warrants | — | — | — | — | — | |||||||||||||||||||||||
| Forfeiture of Class B Shares by Sponsor | — | — | ( | ) | ( | ) | — | — | ||||||||||||||||||||
| Accretion of Class A ordinary shares to redemption amount | — | — | — | — | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
| Net loss | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||
| Balance at March 31, 2022 | $ | $ | $ | $ | ( | )  | $ | ( | )  | |||||||||||||||||||
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||
| Class A Ordinary Shares | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholder’s Equity | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||
| Balance at February 3, 2021 (inception) | $ | $ | $ | $ | $ | |||||||||||||||||||||||
| Issuance of Class B ordinary shares to Sponsor  (1) | — | — | — | |||||||||||||||||||||||||
| Net loss | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||
| Balance at March 31, 2021 | $ | $ | $ | $ | ( | )  | $ | |||||||||||||||||||||
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||
| (1) | Includes up to  | 
| Three Months Ended March 31, 2022 | For the period from February 3, 2021 (inception) through March 31, 2021 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Payment of formation and operating costs through due to related party | ||||||||
| Payment of formation and operating costs through promissory note - related party | ||||||||
| Loss on sale of Private Placement Warrants | ||||||||
| Realized gain on investments held in Trust Account | ( | ) | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | ||||||||
| Accounts payable | ( | ) | ||||||
| Accrued expenses | ||||||||
| Accrued expenses - related party | ||||||||
|  |  |  |  | |||||
| Net cash used in operating activities | ( | )  | ||||||
|  |  |  |  | |||||
| Cash Flows from Investing Activities: | ||||||||
| Cash deposited in Trust Account | ( | ) | ||||||
|  |  |  |  | |||||
| Net cash used in investing activities | ( | )  | ||||||
|  |  |  |  | |||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from Initial Public Offering, net of underwriting discount paid | ||||||||
| Proceeds from sale of Private Placement Warrants | ||||||||
|  |  |  |  | |||||
| Net cash provided by financing activities | ||||||||
|  |  |  |  | |||||
| Net Change in Cash | ( | )  | ||||||
| Cash - Beginning of period | ||||||||
|  |  |  |  | |||||
| Cash - End of period | $ | $ | ||||||
|  |  |  |  | |||||
| Non-cashinvesting and financing activities: | ||||||||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $ | $ | ||||||
|  |  |  |  | |||||
| Deferred offering costs included in accrued offering costs | $ | $ | ||||||
|  |  |  |  | |||||
| Deferred offering costs included in due to related party | $ | $ | ||||||
|  |  |  |  | |||||
| Accretion of Class A ordinary shares subject to redemption to redemption value | $ | $ | ||||||
|  |  |  |  | |||||
| Deferred underwriting fee payable | $ | $ | ||||||
|  |  |  |  | |||||
| Forfeiture of Class B ordinary shares by Sponsor | $ | $ | ||||||
|  |  |  |  | |||||
| March 31, 2022 | December 31, 2021 | |||||||
| Gross proceeds | $ | $ | ||||||
| Less: | ||||||||
| Proceeds allocated to Public Warrants | ( | ) | ( | ) | ||||
| Issuance costs allocated to Class A ordinary shares | ( | ) | ( | ) | ||||
| Plus: | ||||||||
| Accretion of carrying value to redemption value | ||||||||
|  |  |  |  | |||||
| Class A ordinary shares subject to possible redemption | $ | $ | ||||||
|  |  |  |  | |||||
| Three Months Ended March 31, 2022 | For the Period From February 3, 2021 (Inception) Through March 31, 2021 | |||||||||||||||
| Class A | Class B | Class A | Class B | |||||||||||||
| Basic and diluted net loss per share: | ||||||||||||||||
| Numerator: | ||||||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||
|  |  |  |  |  |  |  |  | |||||||||
| Denominator: | ||||||||||||||||
| Basic and diluted weighted average ordinary shares outstanding | ||||||||||||||||
| Basic and diluted net loss per ordinary share | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||
| • | at any time after the warrants become exercisable;  | 
| • | upon a minimum of  | 
| • | if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $ | 
| • | if, and only if, there is a current registration statement in effect with respect to the Class A ordinary shares underlying such warrants.  | 
| Description | Amount at Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||
| March 31, 2022 | ||||||||||||||||
| Assets | ||||||||||||||||
| Investments held in Trust Account: | ||||||||||||||||
| U.S. Treasury Securities Money Market Funds | $ | $ | $ | $ | ||||||||||||
| December 31, 202 1 | ||||||||||||||||
| Assets | ||||||||||||||||
| Investments held in Trust Account: | ||||||||||||||||
| U.S. Treasury Securities Money Market Funds | $ | $ | $ | $ | ||||||||||||
| * | Filed herewith.  | 
| ** | Furnished herewith.  | 
| (1) | Incorporated by reference to the registrant’s Current Report on Form  8-K,filed with the SEC on December 20, 2021. | 
| SWIFTMERGE ACQUISITION CORP. | ||||||
| Date: May 18, 2022 | By: | /s/ John Bremner | ||||
| Name: | John Bremner | |||||
| Title: | Chief Executive Officer | |||||
| SWIFTMERGE ACQUISITION CORP. | ||||||
| Date: May 18, 2022 | By: | /s/ Christopher J. Munyan | ||||
| Name: | Christopher J. Munyan | |||||
| Title: | Chief Financial Officer | |||||